- Home
- TIL vs ECBK Comparison
TIL vs ECBK Comparison
Compare TIL & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- ECBK
- Stock Information
- Founded
- TIL 2018
- ECBK 1919
- Country
- TIL United States
- ECBK United States
- Employees
- TIL N/A
- ECBK N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- ECBK Banks
- Sector
- TIL Health Care
- ECBK Finance
- Exchange
- TIL Nasdaq
- ECBK Nasdaq
- Market Cap
- TIL 177.1M
- ECBK 151.0M
- IPO Year
- TIL 2021
- ECBK N/A
- Fundamental
- Price
- TIL $15.16
- ECBK $16.49
- Analyst Decision
- TIL Strong Buy
- ECBK
- Analyst Count
- TIL 5
- ECBK 0
- Target Price
- TIL $100.67
- ECBK N/A
- AVG Volume (30 Days)
- TIL 82.0K
- ECBK 6.7K
- Earning Date
- TIL 11-13-2025
- ECBK 10-22-2025
- Dividend Yield
- TIL N/A
- ECBK N/A
- EPS Growth
- TIL N/A
- ECBK 104.95
- EPS
- TIL N/A
- ECBK 0.80
- Revenue
- TIL N/A
- ECBK $29,860,000.00
- Revenue This Year
- TIL N/A
- ECBK N/A
- Revenue Next Year
- TIL N/A
- ECBK N/A
- P/E Ratio
- TIL N/A
- ECBK $20.32
- Revenue Growth
- TIL N/A
- ECBK 20.84
- 52 Week Low
- TIL $10.80
- ECBK $12.56
- 52 Week High
- TIL $42.79
- ECBK $17.33
- Technical
- Relative Strength Index (RSI)
- TIL 34.33
- ECBK 61.60
- Support Level
- TIL $18.10
- ECBK $15.20
- Resistance Level
- TIL $20.11
- ECBK $16.29
- Average True Range (ATR)
- TIL 1.37
- ECBK 0.31
- MACD
- TIL -0.25
- ECBK 0.13
- Stochastic Oscillator
- TIL 0.00
- ECBK 100.00
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.